Jensen Lotte, Sloth Birgitte, Krog-Mikkelsen Inger, Flint Anne, Raben Anne, Tholstrup Tine, Brünner Nils, Astrup Arne
Department of Veterinary Pathobiology, and the Center for Advanced Food Studies, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark.
Am J Clin Nutr. 2008 Jan;87(1):97-105. doi: 10.1093/ajcn/87.1.97.
The development of obesity has been suggested to involve plasminogen activator inhibitor-1 (PAI-1) and tissue inhibitor of proteinases-1 (TIMP-1). Plasma PAI-1 is elevated in obesity. A low-glycemic-index (LGI) diet may have a beneficial effect on obesity through a decrease in plasma PAI-1, but whether it affects plasma TIMP-1 in healthy humans has not been studied.
We investigated whether a 10-wk intake of an LGI or a high-glycemic-index (HGI), high-carbohydrate, low-fat, ad libitum diet is associated with decreases in plasma PAI-1 and TIMP-1 concentrations in overweight women.
Forty-four overweight women [body mass index (BMI; in kg/m2): 27.5+/-0.23] were randomly assigned to consume an HGI or an LGI diet for 10 wk. A subgroup of 29 women was assigned to participate in an additional 4-h meal test on the last day of the 10-wk intervention.
PAI-1 activity decreased after 10 wk of the LGI diet and was significantly different between groups. Changes in PAI-1 antigen followed the same trend, but no significant difference was observed between groups. No difference in plasma TIMP-1 concentrations was observed between groups. PAI-1 and TIMP-1 concentrations after the 4-h meal test were not significantly different between groups.
An LGI diet reduces fasting plasma PAI-1 activity and therefore may be useful for diminishing the adverse cardiovascular effects of obesity. This trial was registered at clinicaltrials.gov as NCT00324090.
肥胖的发展被认为与纤溶酶原激活物抑制剂-1(PAI-1)和蛋白酶组织抑制剂-1(TIMP-1)有关。肥胖患者血浆PAI-1水平升高。低升糖指数(LGI)饮食可能通过降低血浆PAI-1对肥胖产生有益影响,但尚未研究其对健康人血浆TIMP-1的影响。
我们研究了超重女性摄入10周LGI饮食或高升糖指数(HGI)、高碳水化合物、低脂、随意饮食是否与血浆PAI-1和TIMP-1浓度降低有关。
44名超重女性[体重指数(BMI;单位:kg/m²):27.5±0.23]被随机分配摄入HGI或LGI饮食10周。29名女性亚组被分配在10周干预的最后一天参加额外的4小时进餐测试。
LGI饮食10周后PAI-1活性降低,且两组间差异显著。PAI-1抗原变化趋势相同,但两组间未观察到显著差异。两组间血浆TIMP-1浓度无差异。4小时进餐测试后两组间PAI-1和TIMP-1浓度无显著差异。
LGI饮食可降低空腹血浆PAI-1活性,因此可能有助于减轻肥胖对心血管的不良影响。该试验在clinicaltrials.gov上注册,注册号为NCT00324090。